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Anaphylatoxins (ATs) 1 are  low-molecular-weight reaction products  of  the 
complement system that have phlogogenic activity. They cause histamine re- 
lease from mast cells,  contraction of smooth muscles, and increased capillary 
permeability. Two  distinct ATs have been  described,  one  derived from the 
third (C3)  and the other from the fifth (C5)  components of complement. They 
are referred to as C3a and CSa, respectively (1). 
The two peptides may readily be obtained from isolated human C3 and C5 
(2-4).  Paradoxically,  their  activities  could  never be  demonstrated in whole 
human serum under conditions known to result in dissociation of C3a and C5a. 
Failure to produce the ATs in human serum had been interpreted in the past to 
indicate that they played no significant role in human biology. The demon- 
stration of a  highly efficient inactivator of the ATs in normal human serum 
(NHS)  offered an alternate explanation (5).  It was postulated that both pep- 
tides are liberated in human serum upon activation of the complement system, 
but that the expression of their biological activity is controlled by the AT in- 
activator (AI). Accordingly, it was anticipated that removal or inhibition of 
the  inactivator  would permit  detection  of  both  activities  in  whole  human 
serum. 
In the following it will be shown that C3a and CSa activity may indeed be 
produced  in  human  serum  from  which  AI  activity has  been  abolished.  A 
method will be described for the isolation of biologically active C5a from whole 
serum; and physical, chemical, and biologic properties of C5a will be compared 
with those of C3a3 
* This is publication  no.  674  from  the Department  of Experimental Pathology, Scripps 
Clinic and Research Foundation, La Jolla, Calif. 92037. 
:~ This work  was  supported  by  U.S.  Public  Health  Service Grant  AI-07007,  American 
Heart  Association,  Inc.,  Grant  71-1020,  and  U.S.  Atomic  Energy  Commission  Contract 
AT  (04-3)-730. 
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Materials and Methods 
Serum.--Serum  was obtained from fresh human  blood, purchased from the San  Diego 
Blood Bank. 
Rabbit Antisera.--Highly purified preparations of AI and rabbit antisera to AI  (5)  and 
to human C3a (7) were obtained as described previously. Antiserum to human C5a was pro- 
duced by injecting 40/tg of isolated CSa in complete Freund's adjuvant into the popliteal 
lymph nodes of rabbits. 3 wk later, 100/zg  of the same material was injected subcutaneously 
and intramuscularly; injections were repeated weekly for 3 wk. 
Immune  Adsorption  of A1  with  Insolubilized Anti-AI.--lO0  ml  of rabbit  antiserum  to 
human AI was mixed with 100 ml of 0.2 M acetate buffer, pH 5.2; the protein was insolubilized 
by the addition of 16 ml of ethyl chloroformate. After thorough washing, the solid material 
(8) was suspended in 10 ml of NHS containing 0.05 M EDTA. The suspension was kept over- 
night at 4°C and then subjected to ultracentrifugation at 20,000 rpm for 1 h in a no. 40 rotor 
and a  Spinco L2  centrifuge (Beckman Instruments, Inc., Palo Alto, Calif.). The recovered 
supernatant was dialyzed against 2  X  10 liters of phosphate buffer, pH 7.0, ionic strength 
0.05. 
Elulion of the Absorbed A/.--The immune adsorbent was washed with 2 X 50 ml phosphate 
buffer, pH 7.0, ionic strength 0.05, and once with 50 ml 1 M NaC1. The absorbed protein was 
then eluted with 3  X  50 ml of 4 M potassium iodide in 0.01 M Tris buffer, pH 8.2, and 0.1% 
bovine serum albumin (BSA)  (9), allowing  15 rain at room temperature for each elution. The 
eluted protein was concentrated in an Amicon concentration device (Amicon  Corp., Lexing- 
ton, Mass.) using an XM-50 ultrafilter. 
Inhibition of AI in It¢~man Serum.--The following  amino acids and their analogues were 
tested: cysteine, arginine HCI,  lysine-HC1, D-tryptophan-methyl ester-HC1,  acetyl-Ldysine, 
hippuryl-L-lysine (Cyclo  Chemical Div.,  Travenol Laboratories, Inc., Los Angeles,  Calif.), 
epsilon-aminocaproic acid  (EACA) (Schwarz/Mann Div., Becton, Dickinson & Co., Orange- 
burg, N. Y.), omega-aminocaprylic acid, pentenoic acid (Sigma Chemical Co., St. Louis, Mo.), 
and CdSO4 (J.  T. Baker Chemical Co., Phillipsburg, N. J.). Samples of NHS were incubated 
with different concentrations of these compounds for 3 h at 37°C or overnight at 4°C. Samples 
of treated serum ranging from 2 to 25/.d were tested for AI activity. 
AT and AI Assays.--AT activity was assayed on segments of isolated guinea pig ileum as 
described previously (4). AI activity was detected by abolition of C3a or C5a activity after 
incubation for 2 min at 23°C and pH 7.5 (5). 
Generation  of C3a and C5a A Ts in Human Serum.--C3a AT was generated by incubation, 
at 37°C for 60 rain, of serum depleted of AI activity by immune adsorption or by inhibition 
with 1 M  EACA. For the production of human C5a AT, AI-depleted serum was treated with 
20 mg/ml of boiled (30 rain)  bakers' yeast at 37°C  for 75  rain.  Standards of C3a and C5a 
ATs were produced by trypsinization of isolated C3 and C5, respectively (4, 7). Porcine AT 
was isolated by a modification of Vogt's method (1). 
Isolalion of C5a A T from tIuman Serum.--Usually 800 ml of fresh NHS was treated for 
16 h at 4°C with 1 M EACA. The serum was then incubated at 37°C for 75 rain with 20 mg/ml 
of boiled (30 min)  bakers' yeast. An equal volume of cold distilled water was then added, 
and the pH was immediately lowered to 3.7 with 1 N HC1 (approximately 800 ml). The reac- 
tion mixture was centrifuged twice at 10,000 rpm for 30 rain to remove the yeast. The super- 
natant was then dialyzed against 2  X  10 liters of 0.1  M  ammonium formate adjusted with 
HC1 to pH 3.7. 
Chromatography  on Carboxymethyl  (CM)-CdlMose.--The dialyzed sample was applied to a 
3.5  X  50 cm column containing CM-cellulose that had been equilibrated with 0.1 M  ammo- 
nium formate, pH 3.7. After application of the sample, the column was washed first with 4 
liters of 0.1 M ammonium formate, pH 3.7, and then with 4 liters of 0.5  M acetic acid. The 
protein was eluted with 0.1 M ammonium formate adjusted with NaOH to pH 7.0. The frac- ENRIQUE H.  VALLOTA AND  HANS  J.  MOLLER-EBERHARD  1111 
tions containing AT activity that eluted between pH 5.5 and 6.5 were pooled, and the pool 
was concentrated to approximately 5 ml in an Amicon (Amicon Corp.) concentration device 
using a UM-2 ultrafilter. 
Molecular Sieve Chromatography.--A 3.5  X  200  cm  Sephadex  G-100  (Pharmacia  Fine 
Chemicals, Inc., Piscataway, N. J.) column was equilibrated with acetic acid-sodium acetate 
buffer, pH 3.7, ionic strength 0.1.  A mixture of the sample and 10% (vol/vol) of a saturated 
sucrose solution was layered between the top of the Sephadex column and the supernatant 
buffer. The flow rate was  12 ml/h, and 3-ml fractions were collected. Fractions containing 
AT activity were pooled and concentrated. 
Chromatography on CM-Sephadex C50.--The concentrated  pools containing AT activity 
from two, and at times three, different gel filtrations were chromatographed, a 2 X  30 cm CM- 
Sephadex C50 column equilibrated with 0.02  M  sodium acetate buffer, pH 5.5,  being used. 
The protein was eluted with a linear salt concentration gradient from a conductance of 2.0-38 
mmho/cm. 500 ml each of 0.02  and 0.5  M  ammonium formate were adjusted with distilled 
water to a conductance of 2 and 38 mmho/cm, respectively. 
Gel Filtration on Sephadex G-25.--A  sample of the active material from the CM-Sephadex 
chromatography was  labeled with  125I (10). The specific  radioactivity was  approximately 
4,500  cpm/#g of protein. Gel filtration was carried out on a  2 )<  90 cm G-25 column equili- 
brated with acetic acid-sodium acetate buffer,  pH 3.7, ionic strength 0.1. The flow rate was 4 
ml/hr and  1-ml fractions were collected. The eluted protein emerged as a single peak  after 
recycling. 
Molecular Weight.--The molecular weight was estimated according to Andrews' method 
(11), employing a 3.5 )< 200 cm Sephadex G-100 column equilibrated with acetic acid-sodium 
acetate buffer,  pH 3.7,  ionic strength 0.1.  As reference substances,  BSA, cytochrome c, and 
glucagon were used. 
The polyacrylamide gel electrophoresis method of Hedrick and  Smith  (12) was also  used 
for determinations of molecular weight. The gel concentration ranged from 5 to 12%. Beta- 
alanine acetic acid buffer, pH 4.5, was employed. Reference substances were lysozyme (14,500), 
papain in its monomeric and dimeric form (21,000 and 42,000),  and trypsin (23,800). 
lmmunochemlcal and Electrophoretic Analyses.--The double diffusion  in gel method was 
used for the detection of AI in NHS, in AI-depleted serum, and in the eluate from the anti-AI 
immune adsorbent. Monospecific rabbit antiserum to AI was used. 
Immunoelectrophoresis was  performed  using  2%  agarose  in  phosphate  buffer,  pH  6.0, 
ionic strength 0.05, with 0.01 M EDTA, and 2% agar in barbital buffer,  pH 8.6, with 0.01 M 
EDTA. Disc electrophoresis was performed according to the method of  Reisfeld et al.  (13), 
6% resolving gel and fl-alanine acetic acid buffer, pH 4.5,  being used.  Analytical electro- 
phoresis on cellulose acetate strips was  carried  out in a  Beckman  (Beckman Instruments, 
Inc., Fullerton, Calif.) mierozone electrophoresis apparatus,  model P,-101, using a Beckman 
barbital buffer (pH 8.5),  ionic strength 0.075,  and 250 V for 20 rain at 20°C. 
RESULTS 
Depletion  of AI  in Human  Serum  by Immune  Adsorption.--Human  serum 
was depleted of AI by immune adsorption. No AI was detectable in the treated 
serum  by  Ouchterlony  test  (Fig.  1).  The  protein  eluted  from  the  immune 
adsorbent  gave  a  precipitin  line  identical  with  the  line  obtained  with  fresh 
NHS,  The  AI-depleted  serum  was  no  longer  able  to  inactivate  isolated  C3a 
and C5a AT activity. The eluted protein that was immunochemically identical 
with AI lacked enzymatic AI activity. The activity was not restored  by addi- 
tion of magnesium chloride or cobalt chloride. 1112  c3a  AND  CSa  FORMATION  AFTER  AI  INHIBITION 
FIG. 1.  Absence of immunochemically detectable AI in immune-adsorbed NHS  (Ads.). 
Analysis was performed by Ouchterlony  test using an anti-AI. The precipitating lines result- 
ing from AI present in NHS (NHS) and the eluted protein from the solidified antibody (El.) 
fused completely. 
AT Generation in  Serum  Depleted of AI  by  Immune  Adsorption.--As  de- 
picted in Fig.  2,  NHS by itself,  after incubation at 37°C, or after activation 
with  inulin,  yeast,  or  immune  complexes,  was  not  able  to  generate  smooth 
muscle contractile activity. However, after removal of AI, contraction of the 
guinea pig ileum was evoked by application  of 50-100 #1 of serum  that had 
been incubated for 60 rain at 37°C. The active material present in the serum 
was functionally identified as C3a since the muscle was unresponsive to  15 #g 
of isolated C3a.  Further activation of the same serum with yeast caused full 
contraction of the  C3a-desensitized guinea pig ileum.  As we shall  show,  this 
material was identifiable with C5a AT. 
Immunoehemical  Demonstration  of  C3a  in  Human  Serum.--AI-depleted 
serum was incubated  at 37°C for 60 rain and  then subjected to immunoelec- 
trophoresis.  The pattern  was developed with  anti-C3a.  C3a was  readily  de- 
tectable  as  a  cathodally migrating protein  (Fig.  3).  An  antiserum  to  C3  re- 
vealed  that  about  50%  of  the  protein  had  undergone  conversion.  Neither 
C3a nor the anodally migrating conversion products can be seen in untreated 
fresh serum. It is of interest that the conversion of C3 and dissociation of active 
C3a occurred at neutral pH. 
Inhibition  of AI in Whole Human Serum by  Various Substances.---The com- 
pounds tested are listed in Table I. Cysteine and the chelators were the most 
effective inhibitors examined. Some amino acids or amino acid analogues were 
also  active,  but  only at relatively high  concentrations.  Compounds with  the 
amino group in the alpha, beta, and omega position were not inhibitory. Of all 
AI inhibitors,  only EACA allowed generation of AT. All other inhibitors also 
inhibited  AT formation.  Inhibition  of AI by EACA and  cadmium sulfate  is ENRIQUE  H.  VALLOTA  AND  HANS  J.  MULLER-EBERHARD  1113 
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FIO. 2. Tracing produced by contraction of guinea pig ileum, showing biological activity 
in AI-depleted serum (NHS Ads.) after incubation at 37°C for 60 min without any additions. 
NHS, incubated NHS at 37°C for 60 min with immune complexes, inulin, or yeast. Repeated 
applications of NHS Ads. produced tachyphylaxis and cross-tachyphylaxis for isolated human 
C3a. However, the muscle was still fully reactive to histamine (H) and to the biological ac- 
tivity generated after incubation of NHS Ads. at 37°C for 60 min with yeast, which could be 
identified with CSa activity. 
Fio. 3.  Immunoelectrophoretic demonstration  of  C3a  in whole human serum. (A)  Un- 
treated  NHS, pattern developed with anti-NHS.  (B)  AI-depleted NHS incubated  at 37°C 
for 20 rain. Pattern was developed with anti-C3a, showing C3a near the cathodal end of the 
slide. (C) Untreated NHS developed with anti-C3a, detecting uncleaved C3. 
similar to  that  of  carboxypeptidase  N  or  kinase I,  described  by Yang  and 
ErdSs (14). These substances do not inhibit kininase II. 
Modes of AT Generation in Whole Human Serum.--Biologically  active C3a 
and CSa may be obtained by treating whole human serum with a  variety of 
substances after inhibition  of AI by EACA. Thus, antigen-antibody  complexes, 1114  c3a  AND  CSa  FORMATION  AFTER  AI  INIIIBITION 
TABLE  I 
Examination of Various Compounds for Inhibitory Effect on Anaphylatoxin Inactivator 
Compound  Concentration* 
AI Inhibition 
(#1 treated serum/10/~g C3a) 
5  10  25 
Cysteine  1  X  10  -2  +++  +++  +++ 
Arginine-HCl  2  M  10  -1  ++  +  - 
Lysine-HC1  7  X  i0  -1  q-++  q-q-  =t= 
Epsilon-aminocaproic acid  3  X  10  -1  @q-q-  -b  - 
D-Tryptophan-methyl ester-HC1  1  X  10  -1  @-}-+  @  -- 
1,10-Phenanthroline  1  X  10  -1  @-~--~  @+@  @+-[- 
EDTA  1  X  10  -2  +++  +++  +++ 
EDTA-Mg  1  X  10  -2  +++  +++  +++ 
CdSO4  3  X  10  -4  q- if- q-  + Jr- +  + 
S-2-aminoethyl-z-cysteine  5  X  10  -1  +++  ++  -- 
Omega-aminocaprylic acid  5  X  10  -1  -  --  NT;~ 
Beta-aminopropionic acid  5  X  10  -1  -  --  NT 
Alpha-aminocaproic acid  5  X  10  -1  --  --  NT 
Pentenoic acid  1  X  10  -1  =t=  -  NT 
Acetyl-L-lysine  5  X  10  -1  --  --  NT 
Hippuryl-L-lysine  5  X  10  -t  --  --  NT 
* The lowest effective concentration or the highest concentration tested. 
Not tested. 
endotoxin,  inulin,  boiled bakers'  yeast,  and  staphylococcal  protein  A  were all 
effective.  Treatment  with  trypsin  also  resulted  in  generation  of  AT,  but  in 
the  appearance  of kinin-like  activity as  well.  For  this  reason,  inulin  or yeast 
were used as activators in all subsequent  experiments. 
Isolation  of C5a  A T from  Human  Serum.--Fresh  NHS  treated  overnight 
with  1 M  EACA  was  used  as  starting  material.  After  activation  with  boiled 
yeast,  the yeast was  removed  and  the pH  was  adjusted  to  3.7.  This material 
was  chromatographed  on  CM-cellulose  in  ammonium  formate,  and  the  AT 
activity was eluted between pH  5.5  and 6.5  (Fig. 4). After concentration,  this 
material was passed  over a  column of Sephadex  G-100. The elution profile and 
the position  of AT  activity in  relation  to known  markers  is illustrated  in  Fig. 
5.  Fractions  containing  AT  activity  from  two,  and  at  times  three,  different 
gel  filtrations  were  pooled  and  chromatographed  using  a  CM-Sephadex  C50 
column (Fig. 6). The peak of activity was eluted at a  conductance of 32 mmho/ 
cm  and  at  a  pH  of  6.2.  After  concentration,  the  active  material  was  passed 
over  a  Sephadex  G-25  column  and  recycled  to  demonstrate  molecular  ho- 
mogeneity of  the  isolated protein  (Fig.  7).  The purification  achieved  at  each 
step  of the isolation procedure  is indicated  in Table II. The average yield was 
250  #g/liter  of  serum.  Usually  17%  of  the  original  activity  present  in  the 
activated  serum  was  recovered.  As  will  be  described  elsewhere,  active  C3a 
could also be isolated from whole human serum containing EACA. ENRIQUE  I-I. VALLOTA AND  HANS  J.  Mt]LLER-EBERHARD  1115 
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FzG. 4.  First preparative step of C5a isolation procedure. Chromatography on CM-cellu- 
lose in a 3.5  X  50 cm column equilibrated with 0.1 M  ammonium formate, pH 3.7. The por- 
tion of the chromatogram representing protein that was not absorbed is not shown. Fractions 
140-220 were pooled and concentrated. 
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FIG. 5.  Molecular sieve chromatography of CSa AT on a  Sephadex G-100 column (2.5)< 
200 cm) at pH 3.7.  For comparison the elution volume of BSA, cytochrome c, and glucagon 
are indicated with their respective molecular weights. 
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FIG. 6.  Third step of C5a AT isolation: chromatography on CM-Sephadex C50. The pro- 
tein was eluted with a gradient increasing in ionic strength and pH, from 2 to 38 mmho/cm 
and from pH 5.5 to 6.5, respectively (pH gradient is not shown). Active fractions were pooled 
and concentrated. 1116  c3a  AND  cSa  FORMATION  AFTER  AI  INHIBITION" 
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FIC. 7.  Elution  diagram of [125I]C5a on a Sephadex G-25 column (2  X 90 cm) in acetic 
acid-sodium acetate  buffer, pH 3.7, ionic strength  0.1. The diagram  represents  the second 
cycle on the same column. 
TABLE II 
Recovery and Yield of Human C5a 
Volume  Protein  Activity  Purification 
ml  mg  rag 
Serum  800  52,000  3.25  -- 
CM-cellulose  5  480  2.5  X  10  -1  1,300 
Sephadex G-100  2  11  1.5  X  10  -3  2,150 
CM-Sephadex C50  0.5  0.2  7.0  X  10  -4  4,600 
Physicochemical  and  Biological  Characterization  of  Human  C5a  AT.--The 
molecular  homogeneity  of  the  isolated  protein  was  ascertained  by  physico- 
chemical  and  immunochemical  studies.  As  shown  in  Fig.  7,  gel  filtration  on 
Sephadex  G-25 demonstrated  a  single major protein peak.  The results of disc 
electrophoresis  and  immunoelectrophoretic  analysis  illustrated  in Figs.  8  and 
9  also showed a  single major protein.  The electrophoretic  mobility of  human 
C5a  was  studied  by  microzone  electrophoresis  and  compared  with  that  of 
pig AT (Fig.  10). By comparison with the known electrophoretic mobilities of 
albumin,  transferrin,  gamma  globulin,  and  human  C3a,  the  mobilities  of 
human  and  pig ATs  were  estimated  to  be,  respectively,  --1.7  and  --1.2  X 
10  .5 cm  2 V -1 s  -t (Fig.  11). 
The diffusion coefficient was estimated  by molecular sieve chromatography 
on  Sephadex  G-100  to be  12.1  X  10.  7 cm2/s and  the molecular weight to be 
17,500 daltons (Fig. 12). By the gel electrophoresis method a molecular weight 
of 16,500 was obtained (Fig. 13). 
The minimal  effective concentration when  CSa AT was tested in the guinea 
pig ileum assay was 7.5  X  10  -~° M. Introduced into the human skin by intra- 
dermal  injection,  the minimal  effective dose required  to produce a  wheal and 
erythema  reaction was  1  X  10  -t5 tool.  As shown in  Fig.  14,  isolated  AT ob- 
tained  by  contact  activation  of  whole  human  serum  produced  completed EN'RIQUE It.  VALLOTA  AND  HANS J.  MI)LLER-EBERIIARD  1117 
Fro. 8.  Demonstration  of CSa by acid polyacrylamide gel electrophoresis (6%) at pH 4.5. 
Top: extinction pattern of gel stained with amido black. Bottom: stained gel (75/zg of pro- 
tein applied). Wire tip indicates position of buffer interface. 
FIG. 9.  Immunoelectrophoretic  demonstration  of C5a  in  2%  agar.  (A)  Immunoelectro- 
phoretic pattern of NHS.  (B)  CSa, no precipitating  line developed with  anti-whole human 
serum. Bottom trough contained anti-C5a. 
desensitization  of the guinea pig ileum to C5a AT obtained by trypsin  treat- 
ment of isolated  C5. As indicated  in the same figure,  this AT was also inacti- 
vated by isolated AI. Smooth muscle-contracting activity was also eluted from 
polyacrylamide gels after electrophoresis  of CSa,  and the activity distribution 
coincided with the protein distribution. 
DISCUSSION 
Our  present  investigations  demonstrated  unequivocally  the  potential  bio- 
logical  significance  of both  human  ATs  and  of  their  control  mechanism,  the 
AI. We showed that removal or inactivation of AI allowed generation of both 1118  c3a  AND  cSa  FORMATION  AFTER  AI  INHIBITION 
FIG. 10.  Microzone electrophoresis  at  pH  8.5  of isolated  human  and  porcine  CSa.  The 
arrow  indicates  the  origin.  For comparison  the electrophoretic patterns  of human  and  pig 
serum are shown. 
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Fio. 11.  Electrophoretic mobilities of human  and porcine CSa ATs in relation to those of 
reference substances.  The electrophoretie mobility was  --1.7  X  10  -5 cm 2 V  -1 s  -1 for the 
human and  --1.2  X  10  -5 cm  2 V  -I s  -1 for the pig AT, respectively. 
ATs, C3a and  CSa, in whole human  serum.  Furthermore,  both fragments could 
be demonstrated  by immunochemical  techniques.  Thus,  the well-known failure 
of human  serum  to  serve  as  a  source  for  ATs  could  be  explained  in  terms  of 
the  function  of  the  AI,  the  previously  described  carboxypeptidase  B  (CPB)- 
like enzyme of normal serum (5). Accordingly, human  serum is not significantly 
different with respect  to AT production  from the sera of other species,  such  as 
pig,  guinea pig,  or rat. ENRIQUE  H. VALLOTA AND  IIANS  J.  MOLLER-EBERIIARD  1119 
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FIG. 12.  Determination of molecular weight of human CSa by the method of Andrews, 
using a G-100 Sephadex column and reference substances. Molecular weight of CSa was found 
to be 17,500 daltons. 
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FIG. 13.  Determination of  molecular weight  of  human C5a  by the  gel  electrophoresis 
method of Hedrick and Smith. The slopes were calculated from log relative mobility vs. gel 
concentration  plots. Solid triangle, lysozyme (mol wt =  14,500). Solid circles, monomeric and 
dimeric form of papain (tool wt =  21,000 and 42,000, respectively). Open circle, trypsin (tool 
wt =  23,800). The molecular weight of C5a was found to be 16,500. 
The difference between human  and, for  instance, porcine serum lies in the 
resistance  of  porcine  CSa  to  inactivation by  autologous  AI.  Further,  a  C3a 
analogue had never been demonstrated in whole serum of any species. As will 
be  shown elsewheref  C3a AT may be produced  in whole porcine serum as it 
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Fla.  14.  Biologic activity  of C5a isolated from yeast-activated  human  serum. Tracing 
produced by guinea pig ileum contraction upon applications of 1/~g of CSa. Repeated appli- 
cation produced desensitization for CSa obtained by trypsin treatment of isolated human C5. 
Tracing on the right shows inactivation of human C5a by AI (AT +  AI). Mter treatment 
of CSa with AI, no contraction could be elicited, whereas identical amounts of untreated C5a 
produced a full contraction (AT). H indicates the effect of histamine. 
was shown in these experiments to arise in whole human serum. However, as in 
human  serum,  it  is  rapidly  inactivated  by  the  porcine  AI.  The  differential 
susceptibility of porcine  C3a  and  C5a  to AI action results in  suppression  of 
C3a  activity and accumulation  of  C5a  activity.  In  contrast,  both  activities 
are  suppressed  in  whole  human  serum.  Formation  and  fate  of  human  and 
porcine ATs  are schematically represented in Fig.  15. The differential effect of 
AI  on  the  ATs  of experimental  animals fully explains  the  fact that  C3a  es- 
caped detection by the earlier students of AT. 
Action  of AI  on  C3a  was  shown  to  result  in  cleavage of  the  C-terminal 
arginine (5). Similarly, preliminary investigations of human CSa indicate that 
this peptide,  too, has a  basic residue in  C-terminal position. Inactivation ap- 
pears  to  be  caused  by removal of the  C-terminal  residue  in  both  instances. 
Since  AI also inactivates porcine  C3a,  its  C  terminus is most probably also 
occupied by a  basic amino acid. The demonstration of a neutral  residue,  leu- 
cine, in C-terminal position for porcine C5a (15) is consistent with the resistance 
of the peptide to inactivation by AI. However, it raises an important question 
as to the identity and bond specificity of the CSa-liberating enzyme in porcine 
serum.  Human  C3a  appears  to  be liberated  by cleavage of  a  peptide  bond 
involving the carboxyl group of arginine  (16).  The same appears to apply to 
human C5a. This is consistent with the tryptic nature of the C3- and C5-acti- 
vating enzymes C4,2  and  C4,2,3.  The  C3  activator  of  the  alternate  mecha- 
nism of complement activation  also is trypsin-like  (17),  and  this  assumption 
may be made for the enzyme liberating porcine C3a. However, if porcine C5a 
is dissociated  from the  N-terminal  portion  of its  precursor  by cleavage of a 
leucyl bond, the bond specificity of the responsible enzyme would be different 
from that of its human  counterpart.  Such  dissimilarity in  enzyme specificity 
within  the same biological system occurring in two mammalian species is im- 
probable. The identity of the C-terminal residue of porcine CSa therefore re- 
quires reexamination. 
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FIO. 15.  Schematic representation of current concept of formation and differential inacti- 
vation of ATs in human and porcine serum. 
Our results indicated that after removal or inactivation of AI, mere incubation 
of NHS at 37°C resulted in generation of biologically and immunochemically 
detectable C3a. Addition of EACA accelerated the  normally slow  conversion 
to such  an extent  that no detectable native  C3 was seen by immunoelectro- 
phoresis  after 4  h  of incubation  (Fig.  3).  Whether  EACA  enhances  a  serum 
enzyme directly or indirectly involved in  C3  conversion or whether  it  inter- 
feres with a serum enzyme inhibitor has not been determined. 
Previously,  human  C5a  was  obtained  by enzymatic  cleavage  of  C5  with 
trypsin  or  the  C4,2,3  enzyme  (4).  Our  results  indicate  that  C5a,  as  is  the 
case for hog and rat ATs, can be generated by activation of whole serum with 
inulin or fresh or boiled bakers' yeast. These substances are known to trigger 
the alternate pathway. Generation of ATs under these conditions was always 
accompanied by conversion of the C3 proactivator (C3PA) to its enzymatically 
active form (20).  Prevention of C3PA  conversion by the use of high doses of 
heparin resulted in prevention of AT generation. Thus, AT formation by the 
methods  used  proceeded  through  the  alternate  mechanism  of  complement 
activation. 
In  the course of this work it was possible to demonstrate human  C5a  AT 
for the first time directly as a protein entity,  through electrophoresis  on acid 
polyacrylamide  gels  or  cellulose  acetate  strips.  The  isolated  peptide  has  a 
molecular weight of 16,500,  which is more than twice that of C3a. It is not as 
basic as C3a; but when tested by intradermal injection in humans for causation 
of wheal and erythema, C5a appears almost 1,000  times more active than C3a 
on a molar basis (6). 
Immunochemical and structural  studies  are under way to define  the  char- 
acteristics  of  isolated  ATs  from  different  species.  For  comparison,  some  of 
the properties of human C3a and C5a are listed in Table III. With the methods 
at hand for isolating both peptides in active form directly from whole serum, 
it  has now  become feasible to undertake  comparative structural  studies  and 
to determine the chemical basis of the AT biologic activities. 1122  C3a  AND  C5a  FORMATION AFTER AI 1NtIIBITION 
TABLE  III 
Properties of Human  C3a and C5a Anaphylatoxins 
C3a  CSa 
Electrophoretic mobility*  +2.1  -- 1.7 
Diffusion coefficient~  --  12.1 
Frictional ratio §  --  1.05 
Molecular weight 
Gel filtration  8,700  17,500 
Gel electrophoresis  7,200  16,500 
Activity 
Minimal effective conch  2.5  X  10  -s M  7.5  X  10  -l° M 
in vitro[[ 
Minimal effective dose  2.1  X  10  -12 tool  1 X  10  -15 tool 
in vivo¶ 
* Cellulose acetate, pH 8.5 (X 10  -5 cm 2 V  -I s-l). 
Sephadex gel filtration (X  10  -7 cm 2 s-l). 
§ Calculated nomographically. 
][ Guinea pig ileum contraction. 
¶ Wheal and erythema in human skin. 
SUMMARY 
TWO  biologically and  chemically distinct  anaphylatoxins  (ATs)  could  be 
generated in whole  human serum  after  removal of  the  AT inactivator (AI) 
by immune-absorption  or after inhibition of AI with 1 M  epsilon-aminocaproic 
acid  (EACA).  Both  human ATs  could  be generated by treatment of  serum 
with  antigen-antibody complexes,  which  activate  the  classical  complement 
pathway, and with inulin or yeast, both of which trigger the alternate pathway. 
The ATs were  isolated from serum in active form and characterized  as  C3a 
and C5a. 
Although  human  C3a  had  been  characterized  previously,  C5a  had  not. 
The molecular weight of human CSa AT was  17,500; its electrophoretic mo- 
bility at pH 8.5 was -1.7  X  10  -~ cm  2 V -1 s  -1. The minimal effective concen- 
tration in vitro was  7.5  X  10  -1° M.  The  minimal effective doses  of  human 
C5a  in producing a  wheal  and  erythema in the  human skin was  1  X  10  -15 
mol. The results strongly suggest a biological function for both ATs and indi- 
cate  that  the  expression of  their  activity is  controlled by the  AI  of  normal 
blood plasma. 
The authors  wish to thank Mrs.  Heike 0tting and Mrs. Arlene Bayne for their skillful 
technical assistance. 
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